Sainte-Justine joins the Quebec clinical research network in oncology
Q-CROC is pleased to welcome the CHU Sainte-Justine as the 11th member-institution of its clinical research network in oncology. CHU Sainte-Justine has positioned […]
En savoir plus
Scientists have identify a DNA signature linked to prostate cancer severity
The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the a comprehensive genetic analysis of prostate cancer tumors in the journal Nature. This […]
50th liaison coordinators meeting
From left to right: Solange Tremblay (CISSS de Laval), Anne Brochu (CIUSSS de l’Estrie – CHUS), Claire Gagnon (CISSS du Bas-Saint-Laurent), Marie Saint-Jacques (CHU […]
Portfolio of clinical trials in oncology in Quebec and databases
Through its role as network coordinator and clinical research development organization, Q-CROC has been able to collect a wide range of relevant evidence […]
Clinical Development Success Rates
The Biotechnology Innovation Organization (BIO) has released the largest ever study of clinical development success rates, with a focus on the advantages of using […]
AstraZeneca launches integrated genomics approach to transform drug discovery and development
AstraZeneca launches integrated genomics approach to transform drug discovery and development. Read the press release: https://www.astrazeneca.com/media-centre/press-releases/2016/AstraZeneca-launches-integrated-genomics-approach-to-transform-drug-discovery-and-development-22042016.html#!
In partnership with Q-CROC, Esperas will invest up to $7M in a clinical trial that aims to provide first access to promising new treatment for Quebec cancer patients
MONTREAL, April 11, 2016 /CNW Telbec/ – Esperas Pharma Inc. (“Esperas”) today announced the initiation of a project to develop a new oral […]